Data Foundry

Drug recalls 2021

Rizatriptan Benzoate Film Coated Tablets — Class III drug recall D-0078-2022

Terminated recall by MACLEODS PHARMA USA, INC, reported 2021-11-03, distributed nationwide. Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Recall numberD-0078-2022
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmMACLEODS PHARMA USA, INC, Princeton, NJ, United States
Recall initiated2021-10-18
Classified2021-10-28
Reported by FDA2021-11-03
Terminated2024-04-24
DistributedNationwide (US)
Reason classesspecification failure
NDC33342-0087, 33342-0087-02, 33342-0087-07, 33342-0087-12, 33342-0087-41, 33342-0087-45, 33342-0087-46, 33342-0087-50, 33342-0087-52, 33342-0087-72, 33342-0088, 33342-0088-02, 33342-0088-07, 33342-0088-12, 33342-0088-41, 33342-0088-45, 33342-0088-46, 33342-0088-50, 33342-0088-52, 33342-0088-72
Lot numbersBRJ2112A, BRJ2113A, BRJ2114A, BRJ2114B
Expiration dates2024-04

Product

Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA

Reason for recall

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0078-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.